{
    "paper_id": "2d50f798a790d6560f81b72b7bf4692cd78a3ce2",
    "metadata": {
        "title": "Journal Pre-proof R\u00e9flexions autour d'une\u00e9volution favorable d'une COVID-19 chez un patient pr\u00e9sentant une schizophr\u00e9nie r\u00e9sistante et sous une association clozapine et Palip\u00e9ridone palmitate",
        "authors": [
            {
                "first": "Noomane",
                "middle": [],
                "last": "Bouaziz",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hamadi",
                "middle": [],
                "last": "Ben",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Rejeb",
                "middle": [],
                "last": "Sarra",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ateb",
                "middle": [
                    "Taoufik"
                ],
                "last": "Fourati",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Francesca",
                "middle": [],
                "last": "Chammas",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Djamel",
                "middle": [],
                "last": "Baha",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Raluka",
                "middle": [],
                "last": "Rosetti",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Khalid",
                "middle": [],
                "last": "Kalalou",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ghassen",
                "middle": [],
                "last": "Saba",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ren\u00e9",
                "middle": [],
                "last": "Benadhira",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Dominique",
                "middle": [],
                "last": "Januel",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. d'une \u00e9volution favorable d'une COVID-19  chez un patient pr\u00e9sentant une schizophr\u00e9nie r\u00e9sistante et  sous une association clozapine et Palip\u00e9ridone La clozapine est l'antipsychotique le plus efficace et la mol\u00e9cule de r\u00e9f\u00e9rence pour le traitement de la schizophr\u00e9nie r\u00e9sistante [1] . Cependant, l'\u00e9pid\u00e9mie actuelle de COVID-19 pose la question de l'initiation ou du maintien de sa prescription dans cette indication.",
            "cite_spans": [
                {
                    "start": 854,
                    "end": 857,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [
                {
                    "start": 575,
                    "end": 723,
                    "text": "d'une \u00e9volution favorable d'une COVID-19  chez un patient pr\u00e9sentant une schizophr\u00e9nie r\u00e9sistante et  sous une association clozapine et Palip\u00e9ridone",
                    "ref_id": null
                }
            ],
            "section": ""
        },
        {
            "text": "En effet, son action immunosuppressive, l'hyper sialorrh\u00e9e fr\u00e9quemment retrouv\u00e9e et le risque d'agranulocytose pourraient augmenter le risque d'infections bact\u00e9riennes ou virales [2] et aggraver ainsi l'infection par COVID-19 [3] .",
            "cite_spans": [
                {
                    "start": 179,
                    "end": 182,
                    "text": "[2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 226,
                    "end": 229,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                }
            ],
            "ref_spans": [],
            "section": "R\u00e9flexions autour"
        },
        {
            "text": "Ces \u00e9l\u00e9ments peuvent dissuader les cliniciens d'initier cette mol\u00e9cule pendant cette p\u00e9riode, les inciter \u00e0 diminuer la posologie des prescriptions en cours, voire \u00e0 les arr\u00eater par pr\u00e9caution.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "R\u00e9flexions autour"
        },
        {
            "text": "Peu de donn\u00e9es dans la litt\u00e9rature sont \u00e0 la disposition du clinicien pour l'aider \u00e0 prendre la d\u00e9cision la plus adapt\u00e9e.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "R\u00e9flexions autour"
        },
        {
            "text": "Nous pr\u00e9sentons le cas d'un patient trait\u00e9 par clozapine associ\u00e9e \u00e0 un antipsychotique d'action prolong\u00e9e, qui a pr\u00e9sent\u00e9 une forme d'\u00e9volution rapidement favorable de COVID-19. Il a alors \u00e9t\u00e9 transf\u00e9r\u00e9 \u00e0 l'unit\u00e9 \u00ab Covid+ \u00bb de notre h\u00f4pital o\u00f9 il a b\u00e9n\u00e9fici\u00e9 d'une surveillance clinique et biologique (tableau 1) avec une dose de clozapine diminu\u00e9e \u00e0 400 mg d\u00e8s son arriv\u00e9e. L'\u00e9volution clinique a rapidement \u00e9t\u00e9 favorable et 14 jours apr\u00e8s le d\u00e9but des sympt\u00f4mes (le 9 avril 2020) le patient est revenu dans notre unit\u00e9.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "R\u00e9flexions autour"
        },
        {
            "text": "Une exaltation thymique constat\u00e9e \u00e0 son arriv\u00e9e a \u00e9t\u00e9 facilement ma\u00eetris\u00e9e par un retour progressif aux doses habituelles de clozapine (600 mg/jour).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "R\u00e9flexions autour"
        },
        {
            "text": "Ce cas clinique illustrant une \u00e9volution favorable d'une infection av\u00e9r\u00e9e COVID-19 chez un patient sous un antipsychotique \u00e0 lib\u00e9ration prolong\u00e9e associ\u00e9 \u00e0 la clozapine et deux thymor\u00e9gulateurs, constitue une donn\u00e9e rassurante qui n\u00e9cessite d'\u00eatre confirm\u00e9e par des donn\u00e9es compl\u00e9mentaires.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "R\u00e9flexions autour"
        },
        {
            "text": "Nous pouvons n\u00e9anmoins \u00e9mettre quelques hypoth\u00e8ses concernant cette \u00e9volution favorable.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "R\u00e9flexions autour"
        },
        {
            "text": "La clozapine, par son potentiel effet immunosuppresseur pourrait exposer les patients \u00e0 un plus grand risque de contracter la COVID-19 mais pourrait aussi en pr\u00e9venir l'\u00e9volution grave. En effet, une des hypoth\u00e8ses des \u00e9volutions s\u00e9v\u00e8res de la maladie COVID-19 serait un emballement immunitaire, m\u00e9di\u00e9 par un orage cytokinique (hypers\u00e9cr\u00e9tion des interleukines 6) [4] .",
            "cite_spans": [
                {
                    "start": 364,
                    "end": 367,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": "R\u00e9flexions autour"
        },
        {
            "text": "Or, la clozapine a un effet immunomodulateur complexe. Elle aurait un effet pro inflammatoire en entra\u00eenant une augmentation initiale (les deux premi\u00e8res semaines de traitement) de l'IL6 puis, \u00e0 partir de la cinqui\u00e8me semaine de traitement, un effet immunosuppresseur avec une augmentation retard\u00e9e et durable de IL-1RA [5] .",
            "cite_spans": [
                {
                    "start": 320,
                    "end": 323,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "R\u00e9flexions autour"
        },
        {
            "text": "Ainsi, si la question de l'instauration de la clozapine en phase d'\u00e9pid\u00e9mie peut se discuter, la clozapine d\u00e9j\u00e0 instaur\u00e9e aurait toute sa place en situation \u00e9pid\u00e9mique. De plus, son efficacit\u00e9 clinique permet une r\u00e9duction de la dur\u00e9e et du nombre d'hospitalisations [6] , limitant ainsi la surcharge des services et potentiellement le risque de contagion intra hospitali\u00e8re.",
            "cite_spans": [
                {
                    "start": 267,
                    "end": 270,
                    "text": "[6]",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": "R\u00e9flexions autour"
        },
        {
            "text": "Il n'y aurait donc pas lieu d'arr\u00eater compl\u00e8tement la clozapine par mesure de pr\u00e9caution en cas d'infection ou d'\u00e9pid\u00e9mie. Les mesures de pr\u00e9cautions habituelles concernant la clozapine devraient suffire. En revanche, Il est important de suivre les recommandations de diminuer les doses de moiti\u00e9 en cas d'\u00e9pisode f\u00e9brile, afin d'\u00e9viter un surdosage de la clozapine [3, 7] .",
            "cite_spans": [
                {
                    "start": 366,
                    "end": 369,
                    "text": "[3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 370,
                    "end": 372,
                    "text": "7]",
                    "ref_id": "BIBREF6"
                }
            ],
            "ref_spans": [],
            "section": "R\u00e9flexions autour"
        },
        {
            "text": "En conclusion, ce cas clinique illustre l'\u00e9volution souvent b\u00e9nigne de la COVID-19 chez les patients atteints de pathologies psychiatriques et sugg\u00e8re l'existence de facteurs de protections li\u00e9s aux effets immunomodulateurs et antiviraux des traitements psychotropes et de la nicotine.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "R\u00e9flexions autour"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Elevated clozapine levels associated with infection: A systematic review",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Clark",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "S"
                    ],
                    "last": "Warren",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Jankowiak",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "O"
                    ],
                    "last": "Schubert",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kisely",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Schizophr Res",
            "volume": "192",
            "issn": "",
            "pages": "50--56",
            "other_ids": {
                "DOI": [
                    "10.1016/j.schres.2017.03.045"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Clozapine is associated with secondary antibody deficiency",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ponsford",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Castle",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tahir",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Robinson",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wade",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Steven",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Br J Psychiatry",
            "volume": "2018",
            "issn": "",
            "pages": "1--7",
            "other_ids": {
                "DOI": [
                    "10.1192/bjp.2018.152"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Consensus statement on the use of clozapine during the COVID-19 pandemic",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Siskind",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "G"
                    ],
                    "last": "Honer",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Clark",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "U"
                    ],
                    "last": "Correll",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hasan",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Howes",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Psychiatry Neurosci",
            "volume": "45",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1503/jpn.200061"
                ]
            }
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Ledford",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nature",
            "volume": "580",
            "issn": "",
            "pages": "311--313",
            "other_ids": {
                "DOI": [
                    "10.1038/d41586-020-01056-7"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "In vivo immunomodulatory effects of clozapine in schizophrenia",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Maes",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Bosmans",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Kenis",
                    "suffix": ""
                },
                {
                    "first": "De",
                    "middle": [],
                    "last": "Jong",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Meltzer",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "Y"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Schizophr Res",
            "volume": "26",
            "issn": "",
            "pages": "57--58",
            "other_ids": {
                "DOI": [
                    "10.1016/s0920-9964(97"
                ]
            }
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "The impact of clozapine initiation and cessation on psychiatric hospital admissions and bed days: a mirror image cohort study",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Siskind",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Reddel",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Maccabe",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kisely",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Psychopharmacology (Berl)",
            "volume": "236",
            "issn": "",
            "pages": "1931--1936",
            "other_ids": {
                "DOI": [
                    "10.1007/s00213-019-5179-6"
                ]
            }
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Clozapine prescription in the wake of the coronavirus (SARS CoV-2) outbreak: What measures? Why?",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ben Dhia",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hamzaoui",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Mouaffak",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Encephale 2020",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.encep.2020.04.001"
                ]
            }
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Smoking, vaping and hospitalization for COVID-19",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Farsalinos",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Barbouni",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Niaura",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.32388/Z69O8A.13"
                ]
            }
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Miyara",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Tubach",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Pourcher",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Morelot-Panzini",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Pernet",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Haroche",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.32388/WPP19W.3"
                ]
            }
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Burkard",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Verheije",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Wicht",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "I"
                    ],
                    "last": "Van Kasteren",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "J"
                    ],
                    "last": "Van Kuppeveld",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Haagmans",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "PLoS Pathog",
            "volume": "10",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1371/journal.ppat.1004502"
                ]
            }
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Lithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Harrison",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Tarpey",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Rothwell",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kaiser",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Hiscox",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Avian Pathol",
            "volume": "36",
            "issn": "",
            "pages": "109--123",
            "other_ids": {
                "DOI": [
                    "10.1080/03079450601156083"
                ]
            }
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Monsieur P. est un patient \u00e2g\u00e9 de 51 ans, suivi depuis l'\u00e2ge de 25 ans pour un trouble schizoaffectif ultra chimio r\u00e9sistant ayant n\u00e9cessit\u00e9 une hospitalisation de 18 mois en unit\u00e9 pour malades difficiles (UMD) jusqu'en janvier 2020. Il est stabilis\u00e9 sur le plan psychiatrique avec un traitement associant : clozapine 600 mg/jour (depuis f\u00e9vrier 2019), palip\u00e9ridone palmitate 50 mg/4 semaines, valproate de sodium 2 g/jour et carbonate de lithium \u00e0 lib\u00e9ration prolong\u00e9e 1 g/jour.Le 24 mars 2020, M. P. a pr\u00e9sent\u00e9 une fi\u00e8vre \u00e0 38.2 puis \u00e0 38,7, s'est plaint de fatigue et d'une toux \u00e9voluant depuis 3 jours.Le patient a alors \u00e9t\u00e9 confin\u00e9 selon les directives de notre \u00e9tablissement et des autorit\u00e9s sanitaires. Il a cependant difficilement support\u00e9 ce confinement en raison de son tabagisme et malgr\u00e9 la pose de patchs nicotiniques. Du fait de la p\u00e9nurie des tests, deux jours ont \u00e9t\u00e9 n\u00e9cessaires avant que le patient puisse b\u00e9n\u00e9ficier du test de d\u00e9pistage (\u00e9couvillonnage nasal), qui s'est av\u00e9r\u00e9 positif.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "palmitate Thoughts on a favourable evolution of a COVID -19 in a patient with resistant schizophrenia and on a combination of clozapine and paliperidone palmitate Noomane BOUAZIZ*, Hamadi BEN REJEB, Sarra ATEB, Taoufik FOURATI, Francesca CHAMMAS, Djamel BAHA, Raluka ROSETTI, Khalid KALALOU, Ghassen SABA, Ren\u00e9 BENADHIRA, Dominique JANUEL",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}